Vnitr Lek 2013, 59(8):720-723

Where is the treatment of hypertension heading?

M. Souček
II. interní klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MUDr. Miroslav Souček, CSc.

High normal blood pressure is defined as pressure of 130-138/85-89 mm Hg. The term prehypertension is used for systolic blood pressure of 120-139 mm Hg and diastolic pressure of 80-89 mm Hg. The question is whether blood pressure at those levels should be treated and if so, in which patients. Another question is, whether the therapy can affect the incidence of hypertension and cardiovascular complications.

Keywords: hypertension; high normal blood pressure; cardiovascular complications; pharmacological treatment

Received: July 11, 2013; Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Souček M. Where is the treatment of hypertension heading? Vnitr Lek. 2013;59(8):720-723.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Filipovský J, Widimský J Jr, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Hypertenze a kardiovaskulární prevence 2012; 3: 1-16.
    2. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2158. Go to original source... Go to PubMed...
    3. Guidelines Committee. 2003 ESH-ESC guidelines for the management od arterial hypertension. J Hypertens 2003; 21: 1011-1053. Go to original source... Go to PubMed...
    4. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the JNC on prevention, detection, evaluation and treatment of high blood pressure. JAMA 2003; 289: 2560-3257. Go to original source... Go to PubMed...
    5. Widimský J Jr, Cífková R, Spinar J et al. Doporučení pro diagnostiku a léčbu arteriální hypertenze. Vnitř Lék 2008; 54: 101-118. Go to PubMed...
    6. Lewington S, Clarke R, Qizilbash N et al. Prospective Studies Collaboration: Age specific relevance of usual blood pressure to vascular modality: a meta-analysis of individual data for 1 milion adults in 61 prospective studies. Lancet 2002; 360: 1903-1913. Go to original source... Go to PubMed...
    7. Hsia J, Margolis KL, Eaton CB et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007; 115: 855-860. Go to original source... Go to PubMed...
    8. Gu Q, Burt VL, Paulose-Ram R et al. High blood pressure and cardiovascular disease modality risk among US adults: the Third National Health and Nutrition Examination Surve-y Mortality Follow-up Study. Ann Epidemiol 2008; 18: 302-309. Go to original source... Go to PubMed...
    9. Dong GH, Wang D, Liu MM et al. Sex difference of the prevalence and risk factors associated with prehypertension aminy urban Chinese adults from 33 communities of China: the CHPSNE study. J Hypertens 2012; 30: 485-491. Go to original source... Go to PubMed...
    10. Mainous AG, Everett CJ, Liszka H et al. Prehypertension and modality in a nationally representative cohort. Am J Cardiol 2004; 94: 1496-1500. Go to original source... Go to PubMed...
    11. Glasser SP, Judd S, Basile J et al. Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geografie and Racial Differences in Stroke (REGARDS) Study. Am J Hypertens 2011; 24: 194-199. Go to original source... Go to PubMed...
    12. Kim BJ, Lee HJ, Sung KC et al. Comparison of mikroa1buminuria in 2 blood pressure categories of prehypertensive subjects. Circ J 2007; 71: 1283-1287. Go to original source... Go to PubMed...
    13. Everett CJ, Frithsen IL. Evidence that prehypertension is a risk factor for type 2. diabetes. Expert Rev Cardiovasc Ther 2010; 8: 335-337. Go to original source... Go to PubMed...
    14. Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124. Go to original source... Go to PubMed...
    15. Svetkey LP, Simons-Morton D, Vollmer WM et al. Effects of dietary patterns on blood subgroup analysis of the dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch intern Med 1999; 159: 285-293. Go to original source... Go to PubMed...
    16. Slimko ML, Mensah GA. The role of diets, food, and nutrients in the prevention and control of hypertension and prehypertension. Cardiol Clin 2010; 28: 665-674. Go to original source... Go to PubMed...
    17. Julius S, Nesbitt SD, Egan BM et al. Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685-1697. Go to original source... Go to PubMed...
    18. Liiders S, Schrader J, Berger J et al. The PHARAO Study: Prevention of hypertension with the ACE inhibitor ramipril in patients with high-normal blood pressure - a prospective randomized, controlled prevention trial of the German Hypertension League. J Hypertens 2008; 26: 1487-1496. Go to original source... Go to PubMed...
    19. Rosolová H. Prehypertenze a vysoký normální krevní tlak. In: Perušičová J (ed). Prediabetes, prehypertenze, dyslipidemie a metabolický syndrom. Praha: Maxdorf 2012: 211-221.
    20. Holman RR, Paul SK, Bethel MA et al. Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes. N Engl J Med 2008; 359: 1575-1576. Go to original source... Go to PubMed...
    21. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.